Ainos (NASDAQ:AIMD – Get Free Report) released its earnings results on Monday. The company reported ($0.09) EPS for the quarter, FiscalAI reports. The firm had revenue of $0.64 million during the quarter.
Ainos Trading Up 7.9%
AIMD stock opened at $1.23 on Wednesday. The firm has a 50 day moving average price of $1.08 and a 200-day moving average price of $1.53. Ainos has a 52-week low of $0.43 and a 52-week high of $3.88.
Analyst Upgrades and Downgrades
Separately, Weiss Ratings upgraded Ainos from a “sell (e+)” rating to a “sell (d-)” rating in a report on Friday, September 25th. One analyst has rated the stock with a Sell rating. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Sell”.
Check Out Our Latest Report on AIMD
About Ainos
Ainos, Inc. is a health technology company developing products that combine artificial intelligence with sensing and diagnostic technologies. Its work includes the AI Nose platform, designed to detect and analyze volatile organic compounds (VOCs) for potential use in health care and other applications. The company also develops VELDONA, a low-dose interferon-alpha product, and point-of-care testing solutions. Ainos focuses on advancing these offerings for human and veterinary health uses, alongside applications for VOC monitoring.
Further Reading
- Five stocks we like better than Ainos
- 3 Stocks Flashing Buy Signals With Historical Win Rates Above 85% After the Sell-Off
- Disney Has the Magic Touch: Dividend Growth and Buybacks Could Fuel a Breakout
- NVIDIA’s Turbulence Could Have Ripple Effects Across Quantum Computing
- Banking on AI: Can Upstart’s New Bank Plan Turn Its Stock Around?
Receive News & Ratings for Ainos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ainos and related companies with MarketBeat.com's FREE daily email newsletter.
